2 Top Biotech Stocks to Buy Right Now

Approval from the U.S. Food and Drug Administration is a big step in the life of a biotech company. It's the difference between theory and reality, between hopes and money in the bank. FDA approval not only means that a company can start selling its drugs, but also that the company might have a government-sanctioned monopoly (because competitors are kept out unless they, too, can survive the FDA gauntlet).

Here are two companies that are facing imminent judgment from the FDA: Amarin (NASDAQ: AMRN) and Blueprint Medicines (NASDAQ: BPMC). Both of these stocks will be a lot higher, or a lot lower, in 2020. Welcome to biotech stock investing!

Image source: Getty Images.

Continue reading

Source Fool.com